Microvascular and lymphatic dysfunction in HFpEF and its associated comorbidities
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1435-1803
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Microvascular and lymphatic dysfunction in HFpEF and its associated comorbidities ; volume:115 ; number:4 ; day:25 ; month:5 ; year:2020 ; pages:1-15 ; date:7.2020
Basic research in cardiology ; 115, Heft 4 (25.5.2020), 1-15, 7.2020
- Creator
-
Cuijpers, Ilona
Simmonds, Steven J.
Bilsen, Marc van
Czarnowska, Elżbieta
González Miqueo, Arantxa
Heymans, Stephane
Kuhn, Annika R.
Mulder, Paul
Ratajska, Anna
Jones, Elizabeth A. V.
Brakenhielm, Ebba
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s00395-020-0798-y
- URN
-
urn:nbn:de:101:1-2020091521134261581315
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:55 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Cuijpers, Ilona
- Simmonds, Steven J.
- Bilsen, Marc van
- Czarnowska, Elżbieta
- González Miqueo, Arantxa
- Heymans, Stephane
- Kuhn, Annika R.
- Mulder, Paul
- Ratajska, Anna
- Jones, Elizabeth A. V.
- Brakenhielm, Ebba
- SpringerLink (Online service)
Other Objects (12)
Inflammation in obesity-related HFpEF: the STEP-HFpEF program
Benefits of peritoneal ultrafiltration in HFpEF and HFrEF patients
NASH triggers cardiometabolic HFpEF in aging mice
Different determinants of exercise capacity in HFpEF compared to HFrEF
Semaglutide in HFpEF across obesity class and by body weight reduction: a prespecified analysis of the STEP-HFpEF trial
Semaglutide in HFpEF across obesity class and by body weight reduction: a prespecified analysis of the STEP-HFpEF trial
Post-discharge changes in nutritional status predict prognosis in patients with acute decompensated HFpEF from the PURSUIT-HFpEF Registry
HFpEF as systemic disease, insight from a diagnostic prediction model reminiscent of systemic inflammation and organ interaction in HFpEF patients
Lifestyle interventions in cardiometabolic HFpEF: dietary and exercise modalities
From Mouse Models to Patients: A Comparative Bioinformatic Analysis of HFpEF and HFrEF
Leucine Supplementation Improves Diastolic Function in HFpEF by HDAC4 Inhibition
Biomarker profiling for risk of future heart failure (HFpEF) development
Inflammation in obesity-related HFpEF: the STEP-HFpEF program
Benefits of peritoneal ultrafiltration in HFpEF and HFrEF patients
NASH triggers cardiometabolic HFpEF in aging mice
Different determinants of exercise capacity in HFpEF compared to HFrEF
Semaglutide in HFpEF across obesity class and by body weight reduction: a prespecified analysis of the STEP-HFpEF trial
Semaglutide in HFpEF across obesity class and by body weight reduction: a prespecified analysis of the STEP-HFpEF trial
Post-discharge changes in nutritional status predict prognosis in patients with acute decompensated HFpEF from the PURSUIT-HFpEF Registry
HFpEF as systemic disease, insight from a diagnostic prediction model reminiscent of systemic inflammation and organ interaction in HFpEF patients
Lifestyle interventions in cardiometabolic HFpEF: dietary and exercise modalities
From Mouse Models to Patients: A Comparative Bioinformatic Analysis of HFpEF and HFrEF
Leucine Supplementation Improves Diastolic Function in HFpEF by HDAC4 Inhibition
Biomarker profiling for risk of future heart failure (HFpEF) development
Inflammation in obesity-related HFpEF: the STEP-HFpEF program
Benefits of peritoneal ultrafiltration in HFpEF and HFrEF patients
NASH triggers cardiometabolic HFpEF in aging mice
Different determinants of exercise capacity in HFpEF compared to HFrEF
Semaglutide in HFpEF across obesity class and by body weight reduction: a prespecified analysis of the STEP-HFpEF trial
Semaglutide in HFpEF across obesity class and by body weight reduction: a prespecified analysis of the STEP-HFpEF trial
Post-discharge changes in nutritional status predict prognosis in patients with acute decompensated HFpEF from the PURSUIT-HFpEF Registry
HFpEF as systemic disease, insight from a diagnostic prediction model reminiscent of systemic inflammation and organ interaction in HFpEF patients
Lifestyle interventions in cardiometabolic HFpEF: dietary and exercise modalities
From Mouse Models to Patients: A Comparative Bioinformatic Analysis of HFpEF and HFrEF
Leucine Supplementation Improves Diastolic Function in HFpEF by HDAC4 Inhibition